Ultragenyx Stock Total Asset
| RARE Stock | USD 46.02 0.38 0.82% |
Ultragenyx fundamentals help investors to digest information that contributes to Ultragenyx's financial success or failures. It also enables traders to predict the movement of Ultragenyx Stock. The fundamental analysis module provides a way to measure Ultragenyx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ultragenyx stock.
Ultragenyx |
Ultragenyx Company Total Asset Analysis
Ultragenyx's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Ultragenyx Total Asset | 1.49 B |
Most of Ultragenyx's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ultragenyx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, Ultragenyx has a Total Asset of 1.49 B. This is 80.17% lower than that of the Biotechnology sector and 24.54% lower than that of the Health Care industry. The total asset for all United States stocks is 94.94% higher than that of the company.
Ultragenyx Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ultragenyx's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ultragenyx could also be used in its relative valuation, which is a method of valuing Ultragenyx by comparing valuation metrics of similar companies.Ultragenyx is currently under evaluation in total asset category among its peers.
Ultragenyx Fundamentals
| Return On Equity | -2.9 | ||||
| Return On Asset | -0.24 | ||||
| Profit Margin | (1.07) % | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 3.7 B | ||||
| Shares Outstanding | 92.34 M | ||||
| Shares Owned By Insiders | 3.62 % | ||||
| Shares Owned By Institutions | 97.49 % | ||||
| Number Of Shares Shorted | 3.18 M | ||||
| Price To Earning | (6.90) X | ||||
| Price To Book | 12.35 X | ||||
| Price To Sales | 8.20 X | ||||
| Revenue | 434.25 M | ||||
| Gross Profit | (370.78 M) | ||||
| EBITDA | (516.45 M) | ||||
| Net Income | (606.64 M) | ||||
| Cash And Equivalents | 542.8 M | ||||
| Cash Per Share | 7.75 X | ||||
| Total Debt | 43.17 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 3.08 X | ||||
| Book Value Per Share | 3.76 X | ||||
| Cash Flow From Operations | (474.81 M) | ||||
| Short Ratio | 5.09 X | ||||
| Earnings Per Share | (6.35) X | ||||
| Price To Earnings To Growth | (0.24) X | ||||
| Target Price | 92.43 | ||||
| Number Of Employees | 1.28 K | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 4.28 B | ||||
| Total Asset | 1.49 B | ||||
| Retained Earnings | (3.39 B) | ||||
| Working Capital | 451.75 M | ||||
| Current Asset | 416.79 M | ||||
| Current Liabilities | 50.43 M | ||||
| Net Asset | 1.49 B |
About Ultragenyx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ultragenyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ultragenyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ultragenyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:Check out Ultragenyx Piotroski F Score and Ultragenyx Altman Z Score analysis. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.